SpotitEarly

SpotitEarly is creating the world’s first at-home cancer breath test that uses artificial intelligence (AI) technology and the extraordinary noses of trained dogs to detect multiple early-stage cancers, including lung, breast, colon, and pancreatic, with 94% accuracy, offering a fast, non-invasive, and affordable alternative to historically costly, hard-to-access scans and diagnostic tools.

North America, United States, New Jersey TechCrunch Disrupt 2025

Details

  • Industries

    Analytics Biotech AI/Machine Learning HealthTech Healthcare

  • Operating Status

    Open

  • Website

    spotitearly.com

Founders

  • Roi Ophir

    Founder

  • Udi Bobrovsky

    Founder

  • Ariel Ben Dayan

    Founder

Highlights as of Sep 8, 2025

  • $26.5M

    Money Raised

Have updates? Send them our way!

Sign up for our newsletter